XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2021   123,622,965      
Beginning balance at Dec. 31, 2021 $ 22,521 $ 12 $ 457,391 $ (430,316) $ (4,566)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock under Employee Stock Purchase Plan (in shares)   81,057      
Issuance of common stock under Employee Stock Purchase Plan 127   127    
Issuance of common stock upon exercise of options (in shares)   11,262      
Issuance of common stock upon exercise of options 21   21    
Issuance of vested restricted stock units (in shares)   89,142      
Issuance of vested restricted stock units 0        
Issuance of common stock through at-the-market offering, net (in shares)   576,418      
Issuance of common stock through at-the-market offering, net 1,675   1,675    
Other financing fees (79)   (79)    
Stock-based compensation expense 2,753   2,753    
Currency translation adjustment (32)       (32)
Net (loss) income 28,778     28,778  
Ending balance (in shares) at Mar. 31, 2022   124,380,844      
Ending balance at Mar. 31, 2022 55,764 $ 12 461,888 (401,538) (4,598)
Beginning balance (in shares) at Dec. 31, 2021   123,622,965      
Beginning balance at Dec. 31, 2021 22,521 $ 12 457,391 (430,316) (4,566)
Increase (Decrease) in Stockholders' Equity          
Currency translation adjustment 86        
Unrealized gain on marketable securities 0        
Net (loss) income 37,379        
Ending balance (in shares) at Jun. 30, 2022   152,713,211      
Ending balance at Jun. 30, 2022 89,606 $ 15 487,008 (392,937) (4,480)
Beginning balance (in shares) at Mar. 31, 2022   124,380,844      
Beginning balance at Mar. 31, 2022 55,764 $ 12 461,888 (401,538) (4,598)
Increase (Decrease) in Stockholders' Equity          
Issuance of vested restricted stock units (in shares)   10,938      
Issuance of common stock and common warrants (in shares)   27,428,572      
Issuance of common stock and common warrants 21,480 $ 3 21,477    
Issuance of common stock, license agreement(in shares)   892,857      
Issuance of common stock, license agreement 1,000   1,000    
Other financing fees 79   79    
Stock-based compensation expense 2,564   2,564    
Currency translation adjustment 118       118
Unrealized gain on marketable securities 0        
Net (loss) income 8,601     8,601  
Ending balance (in shares) at Jun. 30, 2022   152,713,211      
Ending balance at Jun. 30, 2022 $ 89,606 $ 15 487,008 (392,937) (4,480)
Beginning balance (in shares) at Dec. 31, 2022 153,042,435 153,042,435      
Beginning balance at Dec. 31, 2022 $ 93,828 $ 15 493,308 (394,937) (4,558)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock under Employee Stock Purchase Plan (in shares)   108,068      
Issuance of common stock under Employee Stock Purchase Plan 149   149    
Issuance of vested restricted stock units (in shares)   276,480      
Issuance of vested restricted stock units 0        
Stock-based compensation expense 2,276   2,276    
Currency translation adjustment (22)       (22)
Unrealized gain on marketable securities 11       11
Net (loss) income (21,663)     (21,663)  
Ending balance (in shares) at Mar. 31, 2023   153,426,983      
Ending balance at Mar. 31, 2023 $ 74,579 $ 15 495,733 (416,600) (4,569)
Beginning balance (in shares) at Dec. 31, 2022 153,042,435 153,042,435      
Beginning balance at Dec. 31, 2022 $ 93,828 $ 15 493,308 (394,937) (4,558)
Increase (Decrease) in Stockholders' Equity          
Currency translation adjustment (49)        
Unrealized gain on marketable securities 11        
Net (loss) income $ (33,050)        
Ending balance (in shares) at Jun. 30, 2023 153,427,571 153,427,571      
Ending balance at Jun. 30, 2023 $ 65,448 $ 15 498,016 (427,987) (4,596)
Beginning balance (in shares) at Mar. 31, 2023   153,426,983      
Beginning balance at Mar. 31, 2023 74,579 $ 15 495,733 (416,600) (4,569)
Increase (Decrease) in Stockholders' Equity          
Issuance of vested restricted stock units (in shares)   588      
Issuance of vested restricted stock units 0        
Stock-based compensation expense 2,283   2,283    
Currency translation adjustment (27)       (27)
Unrealized gain on marketable securities 0        
Net (loss) income $ (11,387)     (11,387)  
Ending balance (in shares) at Jun. 30, 2023 153,427,571 153,427,571      
Ending balance at Jun. 30, 2023 $ 65,448 $ 15 $ 498,016 $ (427,987) $ (4,596)